SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-17-001394
Filing Date
2017-01-31
Accepted
2017-01-31 17:07:04
Documents
1
Period of Report
2017-01-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 10187
  Complete submission text file 0001179110-17-001394.txt   11530
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Issuer) CIK: 0001360886 (see all company filings)

IRS No.: 710881115 | State of Incorp.: MD | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address
Avendano Rodrigo Alberto (Reporting) CIK: 0001686737 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32966 | Film No.: 17561983